Pritesh Shah Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Pritesh Shah.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Pritesh Shah for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 18 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 19.25 | 12,500 | 240,625 | 37,500 | |
| Jan 18 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 11.85 | 12,500 | 148,125 | 37,500 | |
| Jan 18 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 45.00 | 12,500 | 562,538 | 17,087 | 29.6 K to 17.1 K (-42.25 %) |
| Jan 18 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 19.25 | 12,500 | 240,625 | 29,587 | 17.1 K to 29.6 K (+73.16 %) |
| Jan 18 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 45.00 | 12,500 | 562,538 | 17,087 | 29.6 K to 17.1 K (-42.25 %) |
| Jan 18 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 11.85 | 12,500 | 148,125 | 29,587 | 17.1 K to 29.6 K (+73.16 %) |
| Jan 14 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 11.46 | 17,500 | 200,550 | 7,463 | |
| Jan 14 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 14.37 | 8,751 | 125,752 | 0 | |
| Jan 14 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 42.00 | 17,500 | 735,070 | 17,087 | 34.6 K to 17.1 K (-50.60 %) |
| Jan 14 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 11.46 | 17,500 | 200,550 | 34,587 | 17.1 K to 34.6 K (+102.42 %) |
| Jan 14 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 42.00 | 8,751 | 367,577 | 17,087 | 25.8 K to 17.1 K (-33.87 %) |
| Jan 14 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 14.37 | 8,751 | 125,752 | 25,838 | 17.1 K to 25.8 K (+51.21 %) |
| Jan 11 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 14.37 | 8,988 | 129,158 | 8,751 | |
| Jan 11 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 40.01 | 3,023 | 120,950 | 17,087 | 20.1 K to 17.1 K (-15.03 %) |
| Jan 11 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 40.00 | 5,965 | 238,600 | 20,110 | 26.1 K to 20.1 K (-22.88 %) |
| Jan 11 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 14.37 | 8,988 | 129,158 | 26,075 | 17.1 K to 26.1 K (+52.60 %) |